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Actin is a key protein building block of actin microfilaments, which are constructed and
deconstructed in response to cellular signaling pathways to regulate cellular processes
such as motility, division, and endocytosis.1 Arp2/3 Complex is a 7-subunit protein
complex that is in involved in cellular construction of branched actin networks, functioning
by attaching to the side of a pre-existing actin filament and nucleating a daughter branch.2
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Arp2/3 inhibitor scaffolds were identified using high-throughput screening.4 The
CK-666 inhibitor scaffold stabilizes the inactive conformation of the Arp2/3
complex while the CK-869 inhibitor scaffold destabilizes the active conformation.5
A bulk actin 
polymerization assay is 
used as the key method 
to determine the 
potency of inhibitor 
candidates. Results of 
structure-activity 
relationships will be 
used to evaluate how 
actin inhibition may play 
a role in anticancer 
applications3 and  in 
general actin research.
A B
There is a Cysteine with a sulfur group 
near the site where the CK-869 scaffold 
binds. We plan to alter the R1 group to 
increase the binding strength between the 
inhibitor and Arp2/3. 
There are Aspartic acid residues near 
the site where the CK-666 scaffold 
binds. We plan to alter the indole ring by 
adding a nitrogen at position 4 or 7 to 
increase the number of hydrogen bonds 
between the inhibitor and Arp2/3
Binding Site of CK-666 Binding Site of CK-869
Currently known inhibitors CK-666 and CK-869 must be used in undesirably high
concentrations to achieve complete suppression of Arp2/3 complex in vivo.6 The key
goals of this project are to intelligently design, synthesize, and test the potency of a library
of derivatives of each inhibitor class. Computational docking between proposed inhibitors
and a crystal structure of Arp2/3 complex guided synthesis efforts that produced the
following derivatives of CK-869 and CK-666, which were then studied using an in vitro
actin polymerization assay to determine their potency.
-These molecules are 4-
thiazolidinones
-The most favorable
modification to the A ring
was found to be removal
of one methoxy
substituent
-The meta rather than
para substituent on the B
ring was favorable
-Bromine was generally
the best substituent on the
B ring
-AI2-037 showed a ~5 fold
increase in inhibitory
potency
Curve Fit of maximum
polymerization rates
vs. concentration gives
IC50 using the following
fitting equation (m0 =
inhibitor concentration,
m3 = IC50):
7
𝑅 𝐼 = 𝑅𝑎𝑡𝑒𝑚𝑎𝑥 −
𝑅𝑎𝑡𝑒𝑚𝑎𝑥 − 𝑅𝑎𝑡𝑒𝑚𝑖𝑛
𝐼𝐶50
𝐼
-These molecules are
acyl tryptamines
-Modification at the 7
position of the indole ring
is generally favorable
-Modification of the para
position of the
fluorobenzene ring with a
methoxy group slightly
negatively affects potency
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